Media Summary: Oklahoma Heart Institute (OHI) is participating in the Can creating a shunt between the left atrium and the coronary sinus improve symptoms for patients with heart failure with ... Contemporary outcomes in no-option chronic limb-threatening ischemia (Source: Anahita Dua et al. 2025) The CLariTI study ...
Alt Flow Ii Clinical Trial - Detailed Analysis & Overview
Oklahoma Heart Institute (OHI) is participating in the Can creating a shunt between the left atrium and the coronary sinus improve symptoms for patients with heart failure with ... Contemporary outcomes in no-option chronic limb-threatening ischemia (Source: Anahita Dua et al. 2025) The CLariTI study ... We are joined by Dr Firas Zahr (OHSU Knight Cardiovascular Institute Cardiology Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Richard Pratley, MD discuss insights from the Healy could you please tell us more about the aims and objectives of the assert to
Topic: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC In this edition of Journal Club, Daniel M. Alyesh, MD, FHRS and Atul Verma, MD, FHRS dive into the OCEAN In this interview, Dr Adam DeVore (Duke University School of Medicine, Durham, NC) discusses the key findings of the ... On October 21, 2025, results from Alector Therapeutics' Phase 3 Drs Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano) and Babar Basir (Henry Ford Hospital, US) deliver a short, ... Paulus Kirchhof, MD interviews investigator Ulf Landmesser, MD about the results of CLOSURE-AF, which he presented during ...
